Breast cancer patients have a better chance of survival if they are given psychological support in the form of group sessions with a psychologist, according to a report published online Nov. 17 in Cancer.
Breast cancer patients have a better chance of survival if they are given psychological support in the form of group sessions with a psychologist, according to a report published online Nov. 17 in Cancer.
Barbara L. Andersen, PhD, of Ohio State University in Columbus, and colleagues conducted a study of 227 patients who had undergone surgery for regional breast cancer. At baseline, the subjects were given a psychological and behavioral evaluation and were then randomized to either assessment alone or assessment and sessions of psychologist-led small group therapy that included strategies to maintain treatment adherence, reduce stress, and change health behaviors.
During a median 11 years of follow-up, 62 of 212 women (29%) had a recurrence of breast cancer and 54 of 227 (24%) died, the researchers report. Patients who were in the assessment-only arm had a higher risk of both breast cancer recurrence and death compared to those in the intervention arm, the investigators found. The intervention group also had a lower risk of all-cause death, the data revealed.
“If efficacious psychologic interventions to reduce stress are delivered early, they will improve mental health, health and treatment-relevant behaviors, and potentially, biologic outcomes,” the authors write. “If so, there is the possibility for improved survivorship and survival for cancer patients.”
Andersen BL, Yang HC, Farrar WB, et al. Psychologic intervention improves survival for breast cancer patients: randomized clinical trial. Cancer. 2008;17:3450-3458. DOC; 10.1002/cncr.23969.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More